Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • AngA34
    Junior Member
    • Jul 2014
    • 1

    sample cleanup question

    Hi everyone,

    Does anyone know if Exo/SAP PCR cleanup is compatible with MiSeq Illuina sequencing?

    I am preparing some environmental DNA for MiSeq Illumina sequencing. I have done the first round of PCR with 16S bacterial primers which have overhangs that will be used by the sequencing facility to perform a second round of PCR where they would attach the Illumina adaptors. My question is, is ExoSAP PCR cleanup of this first round of PCR compatible with their 2nd round of PCR and the Illumina MiSeq platform? Is there anything in the PCR reaction (normal PCR reaction performed with 3%v/v DMSO) or in the Exo/SAP reaction, that could interfere with lib preparation or sequencing? Does anyone have experience with this?

    Thank you
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    ExoSAP-IT will remove nucleotides and remaining primers. I see two potential issues. If the first PCR has primer dimers, they will not be removed which may cause issues in 2nd PCR (such as preferential amplification of dimers rather than target region). Also, depending on how much of 1st PCR product is used as template for 2nd PCR, it may disturb buffer composition which may affect PCR efficiency. Using ExoSAP-IT for library clean up (2nd PCR) will leave all the primer-dimers and small artefact fragments in, which will result in sequencing those rather than target fragments.

    Comment

    • cement_head
      Senior Member
      • Mar 2012
      • 264

      #3
      I'm not so sure that primer dimers would be an issue - it seems to be able to clean-up Adaptors.
      Attached Files

      Comment

      • cement_head
        Senior Member
        • Mar 2012
        • 264

        #4
        Originally posted by cement_head View Post
        I'm not so sure that primer dimers would be an issue - it seems to be able to clean-up Adaptors.
        Nope, won't work for NGS - just spoke with them - they've tried and doesn't.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        14 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        28 views
        0 reactions
        Last Post SEQadmin2  
        Working...